Literature DB >> 26261534

MiR-126 regulated breast cancer cell invasion by targeting ADAM9.

Cheng-Zheng Wang1, Peng Yuan1, Yin Li2.   

Abstract

Accumulating evidence has shown that microRNAs (miRNAs) deregulation is commonly observed in human malignancies and crucial to cancer metastasis. Herein, we demonstrated that miR-126 play a suppressor role in human breast cancer cells invasion through the direct repression of a disintegrin and metalloprotease 9 (ADAM9). MiR-126 expression was investigated in forty cases of breast cancer specimens by real-time PCR. Transwell assay was conducted to explore the effects of miR-126 on the invasion of human breast cancer cell lines. The impact of miR-126 overexpression on putative target ADAM9 was subsequently confirmed by Western blot analysis. Our results indicated that miR-126 expression was frequently down-regulated in breast cancer specimens compared with adjacent normal tissues (P<0.05). Overexpression of miR-126 significantly reduced (P<0.05) the protein levels of ADAM9, further suppressed (P<0.05) breast cancer cell invasion in vitro. Meanwhile, knockdown of ADAM9 by small interfering RNA (siRNA) also inhibited (P<0.05) breast cancer cell invasion. Thus, our study revealed that miR-126 may act as a tumor suppressor via inhibition of cell invasion by downregulating ADAM9 in breast cancer development.

Entities:  

Keywords:  ADAM9; MiR-126; breast cancer; invasion

Mesh:

Substances:

Year:  2015        PMID: 26261534      PMCID: PMC4525868     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  31 in total

Review 1.  Active metalloproteases of the A Disintegrin and Metalloprotease (ADAM) family: biological function and structure.

Authors:  Theo Klein; Rainer Bischoff
Journal:  J Proteome Res       Date:  2010-10-14       Impact factor: 4.466

2.  Overexpression of ADAM9 enhances growth factor-mediated recycling of E-cadherin in human colon cancer cell line HT29 cells.

Authors:  Takafumi Hirao; Daisuke Nanba; Motonari Tanaka; Hiroshi Ishiguro; Yumi Kinugasa; Yuichiro Doki; Masahiko Yano; Nariaki Matsuura; Morito Monden; Shigeki Higashiyama
Journal:  Exp Cell Res       Date:  2005-12-05       Impact factor: 3.905

3.  ADAM9 promotes lung cancer metastases to brain by a plasminogen activator-based pathway.

Authors:  Chen-Yuan Lin; Hung-Jen Chen; Cheng-Chung Huang; Liang-Chuan Lai; Tzu-Pin Lu; Guan-Chin Tseng; Ting-Ting Kuo; Qian-Yu Kuok; Jennifer L Hsu; Shian-Ying Sung; Mien-Chie Hung; Yuh-Pyng Sher
Journal:  Cancer Res       Date:  2014-07-24       Impact factor: 12.701

4.  Identification of circulating microRNA signatures for breast cancer detection.

Authors:  Maurice Chan; Chiew Suan Liaw; Shen Mo Ji; Hwee Huang Tan; Chow Yin Wong; Aye Aye Thike; Puay Hoon Tan; Gay Hui Ho; Ann Siew-Gek Lee
Journal:  Clin Cancer Res       Date:  2013-06-24       Impact factor: 12.531

5.  Increased expression of ADAM family members in human breast cancer and breast cancer cell lines.

Authors:  Uwe Lendeckel; Jana Kohl; Marco Arndt; Stacy Carl-McGrath; Hans Donat; Christoph Röcken
Journal:  J Cancer Res Clin Oncol       Date:  2004-09-30       Impact factor: 4.553

6.  MicroRNAs and metastasis-related gene expression in Egyptian breast cancer patients.

Authors:  Mohamed M Hafez; Zeinab K Hassan; Abdel Rahman N Zekri; Ayman A Gaber; Salem S Al Rejaie; Mohamed M Sayed-Ahmed; Othman Al Shabanah
Journal:  Asian Pac J Cancer Prev       Date:  2012

7.  Low expression of miR-126 is a prognostic marker for metastatic clear cell renal cell carcinoma.

Authors:  Heba W Z Khella; Andreas Scorilas; Roy Mozes; Lorna Mirham; Evi Lianidou; Sergey N Krylov; Jason Y Lee; Michael Ordon; Robert Stewart; Michael A S Jewett; George M Yousef
Journal:  Am J Pathol       Date:  2015-01-05       Impact factor: 4.307

Review 8.  Breast cancer: a review for the general surgeon.

Authors:  Cindy B Matsen; Leigh A Neumayer
Journal:  JAMA Surg       Date:  2013-10       Impact factor: 14.766

Review 9.  Multidrug-resistant breast cancer: current perspectives.

Authors:  Heather L Martin; Laura Smith; Darren C Tomlinson
Journal:  Breast Cancer (Dove Med Press)       Date:  2014-01-10

10.  Plasma microRNA panel for minimally invasive detection of breast cancer.

Authors:  Katarina Cuk; Manuela Zucknick; Dharanija Madhavan; Sarah Schott; Michael Golatta; Jörg Heil; Frederik Marmé; Andrey Turchinovich; Peter Sinn; Christof Sohn; Hans Junkermann; Andreas Schneeweiss; Barbara Burwinkel
Journal:  PLoS One       Date:  2013-10-23       Impact factor: 3.240

View more
  30 in total

1.  Tumor-suppressive microRNA-452 inhibits migration and invasion of breast cancer cells by directly targeting RAB11A.

Authors:  Wanjun Li; Guoyin Li; Zhigang Fan; Tao Liu
Journal:  Oncol Lett       Date:  2017-06-20       Impact factor: 2.967

2.  Deletion of ADAM-9 in HGF/CDK4 mice impairs melanoma development and metastasis.

Authors:  N Giebeler; A Schönefuß; J Landsberg; T Tüting; C Mauch; P Zigrino
Journal:  Oncogene       Date:  2017-05-29       Impact factor: 9.867

3.  Relevance of A Disintegrin and Metalloproteinase Domain-Containing (ADAM)9 Protein Expression to Bladder Cancer Malignancy.

Authors:  Michika Moriwaki; Trang Thi-Huynh Le; Shian-Ying Sung; Yura Jotatsu; Youngmin Yang; Yuto Hirata; Aya Ishii; Yi-Te Chiang; Kuan-Chou Chen; Katsumi Shigemura; Masato Fujisawa
Journal:  Biomolecules       Date:  2022-06-06

Review 4.  The pleiotropic roles of ADAM9 in the biology of solid tumors.

Authors:  Victor O Oria; Paul Lopatta; Oliver Schilling
Journal:  Cell Mol Life Sci       Date:  2018-03-17       Impact factor: 9.261

Review 5.  The associations and roles of microRNA single-nucleotide polymorphisms in cervical cancer.

Authors:  Yaheng Li; Chuanyin Li; Shuyuan Liu; Jia Yang; Li Shi; Yufeng Yao
Journal:  Int J Med Sci       Date:  2021-04-07       Impact factor: 3.738

Review 6.  Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review).

Authors:  Roberto Gambari; Eleonora Brognara; Demetrios A Spandidos; Enrica Fabbri
Journal:  Int J Oncol       Date:  2016-05-04       Impact factor: 5.650

7.  Downregulation of Microrna-126 Contributes to Tumorigenesis of Squamous Tongue Cell Carcinoma via Targeting KRAS.

Authors:  Jingying Han; Lina Wang; Xiaofeng Wang; Kun Li
Journal:  Med Sci Monit       Date:  2016-02-17

8.  Effects of Folic Acid on Secretases Involved in Aβ Deposition in APP/PS1 Mice.

Authors:  Tian Tian; Dong Bai; Wen Li; Guo-Wei Huang; Huan Liu
Journal:  Nutrients       Date:  2016-09-09       Impact factor: 5.717

9.  Plasma microRNA panels to diagnose pancreatic cancer: Results from a multicenter study.

Authors:  Zhe Cao; Chang Liu; Jianwei Xu; Lei You; Chunyou Wang; Wenhui Lou; Bei Sun; Yi Miao; Xubao Liu; Xiaowo Wang; Taiping Zhang; Yupei Zhao
Journal:  Oncotarget       Date:  2016-07-05

10.  MicroRNA-126 overexpression rescues diabetes-induced impairment in efferocytosis of apoptotic cardiomyocytes.

Authors:  Sahana Suresh Babu; Rajarajan A Thandavarayan; Darukeshwara Joladarashi; Prince Jeyabal; Shashirekha Krishnamurthy; Arvind Bhimaraj; Keith A Youker; Prasanna Krishnamurthy
Journal:  Sci Rep       Date:  2016-11-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.